FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108201722> ?p ?o ?g. }

• W2108201722 endingPage "221" @default.
• W2108201722 startingPage "214" @default.
• W2108201722 abstract "BACKGROUND AND PURPOSE: The MR imaging characteristics of oligodendrogliomas and astrocytomas on spin-echo (SE), echo-planar relative cerebral blood volume (rCBV) maps, to our knowledge, have not previously been emphasized. We compared the specificity of SE rCBV mapping with that of conventional, contrast material–enhanced MR imaging in differentiating high- from low-grade glial tumors and in predicting survival of patients with these lesions. METHODS: Thirty consecutive adult patients with suspected gliomas underwent conventional and rCBV MR imaging. Representative maximal rCBV regions of interest were chosen from each lesion. Resultant values were normalized to those of corresponding, contralateral, uninvolved regions. These normalized CBV (nCBV) values were correlated with degree of contrast enhancement, histopathologic tumor grade, and survival. RESULTS: Twenty-two patients had astroctyomas and eight had oligodendrogliomas. With an nCBV cutoff ratio of 1.5, 13 of 13 high-grade astrocytomas were correctly categorized, three of which did not enhance. Seven of nine low-grade astrocytomas were correctly classified by their nCBV values, including one enhancing lesion. Of eight oligodendrogliomas, four of four high-grade and two of four low-grade tumors had elevated nCBV values; two low-grade oligodendrogliomas enhanced, one with nCBV greater than 1.5 and one with nCBV less than 1.5. In 19 patients with astrocytoma for whom survival data were available, correlation with survival was better for nCBV (mean survival 91 ± 14 months for nCBV 1.5, P P = .03). CONCLUSION: Elevated SE rCBV was a sensitive, but not specific, marker for high-grade histopathology: all high-grade tumors had nCBV foci values greater than 1.5. No tumor with nCBV region of interest less than 1.5 was high grade (100% predictive value for excluding high grade). Degree of nCBV elevation was a stronger predictor of both tumor grade and survival than was degree of enhancement. A significant proportion of low-grade glial neoplasms, most notably oligodendrogliomas, may display high rCBV foci not reflective of high-grade histopathology." @default.
• W2108201722 created "2016-06-24" @default.
• W2108201722 creator A5000127959 @default.
• W2108201722 creator A5001107177 @default.
• W2108201722 creator A5001364155 @default.
• W2108201722 creator A5004268054 @default.
• W2108201722 creator A5010618269 @default.
• W2108201722 creator A5014069251 @default.
• W2108201722 creator A5021024047 @default.
• W2108201722 creator A5029638311 @default.
• W2108201722 creator A5031248234 @default.
• W2108201722 creator A5055927065 @default.
• W2108201722 creator A5056495689 @default.
• W2108201722 creator A5071392806 @default.
• W2108201722 creator A5082115758 @default.
• W2108201722 creator A5088701596 @default.
• W2108201722 date "2004-02-01" @default.
• W2108201722 modified "2023-10-10" @default.
• W2108201722 title "Glial Tumor Grading and Outcome Prediction Using Dynamic Spin-Echo MR Susceptibility Mapping Compared with Conventional Contrast-Enhanced MR: Confounding Effect of Elevated rCBV of Oligodendroglimoas" @default.
• W2108201722 cites W1806268 @default.
• W2108201722 cites W1917703525 @default.
• W2108201722 cites W1973760073 @default.
• W2108201722 cites W1982904703 @default.
• W2108201722 cites W2007496529 @default.
• W2108201722 cites W2009018602 @default.
• W2108201722 cites W2011575415 @default.
• W2108201722 cites W2019540655 @default.
• W2108201722 cites W2022912277 @default.
• W2108201722 cites W2026901966 @default.
• W2108201722 cites W2049726712 @default.
• W2108201722 cites W2057966391 @default.
• W2108201722 cites W2068823347 @default.
• W2108201722 cites W2071752743 @default.
• W2108201722 cites W2074078695 @default.
• W2108201722 cites W2079034377 @default.
• W2108201722 cites W2085277801 @default.
• W2108201722 cites W2088774650 @default.
• W2108201722 cites W2091455840 @default.
• W2108201722 cites W2093055098 @default.
• W2108201722 cites W2094970902 @default.
• W2108201722 cites W2133672120 @default.
• W2108201722 cites W2142199963 @default.
• W2108201722 cites W2164639352 @default.
• W2108201722 cites W2409548872 @default.
• W2108201722 cites W2418679270 @default.
• W2108201722 cites W2433410885 @default.
• W2108201722 cites W2556719987 @default.
• W2108201722 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7974605" @default.
• W2108201722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14970020" @default.
• W2108201722 hasPublicationYear "2004" @default.
• W2108201722 type Work @default.
• W2108201722 sameAs 2108201722 @default.
• W2108201722 citedByCount "146" @default.
• W2108201722 countsByYear W21082017222012 @default.
• W2108201722 countsByYear W21082017222013 @default.
• W2108201722 countsByYear W21082017222014 @default.
• W2108201722 countsByYear W21082017222015 @default.
• W2108201722 countsByYear W21082017222016 @default.
• W2108201722 countsByYear W21082017222017 @default.
• W2108201722 countsByYear W21082017222018 @default.
• W2108201722 countsByYear W21082017222019 @default.
• W2108201722 countsByYear W21082017222020 @default.
• W2108201722 countsByYear W21082017222021 @default.
• W2108201722 countsByYear W21082017222022 @default.
• W2108201722 countsByYear W21082017222023 @default.
• W2108201722 crossrefType "journal-article" @default.
• W2108201722 hasAuthorship W2108201722A5000127959 @default.
• W2108201722 hasAuthorship W2108201722A5001107177 @default.
• W2108201722 hasAuthorship W2108201722A5001364155 @default.
• W2108201722 hasAuthorship W2108201722A5004268054 @default.
• W2108201722 hasAuthorship W2108201722A5010618269 @default.
• W2108201722 hasAuthorship W2108201722A5014069251 @default.
• W2108201722 hasAuthorship W2108201722A5021024047 @default.
• W2108201722 hasAuthorship W2108201722A5029638311 @default.
• W2108201722 hasAuthorship W2108201722A5031248234 @default.
• W2108201722 hasAuthorship W2108201722A5055927065 @default.
• W2108201722 hasAuthorship W2108201722A5056495689 @default.
• W2108201722 hasAuthorship W2108201722A5071392806 @default.
• W2108201722 hasAuthorship W2108201722A5082115758 @default.
• W2108201722 hasAuthorship W2108201722A5088701596 @default.
• W2108201722 hasConcept C126838900 @default.
• W2108201722 hasConcept C127413603 @default.
• W2108201722 hasConcept C142724271 @default.
• W2108201722 hasConcept C143409427 @default.
• W2108201722 hasConcept C147176958 @default.
• W2108201722 hasConcept C2777286243 @default.
• W2108201722 hasConcept C2778227246 @default.
• W2108201722 hasConcept C2778880634 @default.
• W2108201722 hasConcept C2781156865 @default.
• W2108201722 hasConcept C2982720008 @default.
• W2108201722 hasConcept C2989005 @default.
• W2108201722 hasConcept C502942594 @default.
• W2108201722 hasConcept C544855455 @default.
• W2108201722 hasConcept C71924100 @default.
• W2108201722 hasConceptScore W2108201722C126838900 @default.
• W2108201722 hasConceptScore W2108201722C127413603 @default.
• W2108201722 hasConceptScore W2108201722C142724271 @default.
• W2108201722 hasConceptScore W2108201722C143409427 @default.

• next